U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
IMMUNOGLOBULIN, ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-ORYCTOLAGUS CUNICULUS CLONE 284A10 SINGLE-CHAIN VARIABLE FRAGMENT VL-(GGGGS)4-VH) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN CD19 ANTIGEN)
Preferred Name English
EMFIZATAMAB
INN  
Official Name English
emfizatamab [INN]
Common Name English
Code System Code Type Description
INN
12023
Created by admin on Wed Apr 02 10:17:08 GMT 2025 , Edited by admin on Wed Apr 02 10:17:08 GMT 2025
PRIMARY
NCI_THESAURUS
C178448
Created by admin on Wed Apr 02 10:17:08 GMT 2025 , Edited by admin on Wed Apr 02 10:17:08 GMT 2025
PRIMARY
FDA UNII
FB8PCJ9N3H
Created by admin on Wed Apr 02 10:17:08 GMT 2025 , Edited by admin on Wed Apr 02 10:17:08 GMT 2025
PRIMARY
CAS
2559704-23-1
Created by admin on Wed Apr 02 10:17:08 GMT 2025 , Edited by admin on Wed Apr 02 10:17:08 GMT 2025
PRIMARY
SMS_ID
300000042776
Created by admin on Wed Apr 02 10:17:08 GMT 2025 , Edited by admin on Wed Apr 02 10:17:08 GMT 2025
PRIMARY
ACTIVE MOIETY
EMFIZATAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966